Enzo ransomware attack

 On April 6, 2023, Enzo Biochem, Inc. (the "Company") experienced a ransomware attack that impacted certain information technology systems. In response, the Company promptly deployed containment measures, including disconnecting its systems from the internet, and launched an investigation with assistance from third-party cybersecurity experts. The Company has activated its disaster recovery plan, which allows it to continue operations while it brings its systems back online.

On April 11, 2023, the Company became aware that certain data was extracted from the Company's information technology systems as part of this incident. The investigation of this incident and the assessment of its impact is ongoing.

The Company's facilities remain open, and it continues to provide services to its patients and partners using established back-up processes and other downtime procedures. However, these back-up procedures can create operational challenges and have caused delays in the processing of laboratory specimens. The Company is actively engaged in fully restoring or replacing affected systems, which is expected to be largely complete in the coming days.

The Company is also evaluating the extent of the incident and working diligently to mitigate its effects. The Company has incurred, and may continue to incur, certain expenses related to this attack, including expenses to respond to, remediate and investigate this matter. Further, the Company remains subject to risks and uncertainties as a result of the incident, including as a result of the data that was extracted from the Company's network as noted above.

https://www.marketscreener.com/quote/stock/ENZO-BIOCHEM-INC-12466/news/ENZO-BIOCHEM-INC-Other-Events-Financial-Statements-and-Exhibits-form-8-K-43489954/